Diagnostic and Therapeutic Challenges of Rare Urogenital Cancers: Urothelial Carcinoma of the Renal Pelvis, Ureters and Urethra

Overview

Journal World J Oncol

Specialty Oncology

Date 2021 Mar 19

PMID 33738002

Citations 11

Authors

Ayun Cassell 3rd

Burgess Manobah

Soeghen Willie

Affiliations

Soon will be listed here.

Abstract

Urothelial carcinoma (UC) is a neoplastic growth that affects the lining of the urinary tract from the renal pelvis to the distal urethra. Urothelial cancer occurs less commonly along the upper urinary tract (renal pelvis and ureter) accounting for 5-10% and even rarer along the urethra approximately less than 1%. The incidence of UC of the upper urinary tract and urethra has been reported in the United States and Europe by the Surveillance, Epidemiology, and End Results Program and the Rare Cancers in Europe project, respectively. Considering the rarity of upper tract urothelial carcinoma (UTUC) and primary urethral cancer (PUC), there is a paucity of data from Sub-Saharan Africa. Both the European Association of Urology guideline and the National Comprehensive Cancer Network guideline have provided some clinical updates on the management of UTUC and PUC. However, UTUC and PUC present mostly at a more advanced stage than UC of bladder. A high index of suspicion is necessary for diagnosis even more for UTUC. Organ-sparing surgery is possible for both localized UTUC and PUC but stringent follow-up with urine cytology, endoscopy and imaging is mandated for early detection of recurrence.

Citing Articles

Organ-preserving surgery for male distal primary urethral carcinoma: A case report from a tertiary hospital in Ethiopia.

Hirpo A, Akasa S, Ahmed M, Dino M, Molla W, Kidane M Int J Surg Case Rep. 2025; 127:110983.

PMID: 39889659 PMC: 11821390. DOI: 10.1016/j.ijscr.2025.110983.

Gasdermin D (GSDM D) as a Potential Diagnostic Biomarker in Bladder Cancer: New Perspectives in Detection.

Gudowska-Sawczuk M, Paczek S, Olkowicz M, Kudelski J, Mroczko B Cancers (Basel). 2025; 16(24.

PMID: 39766111 PMC: 11674414. DOI: 10.3390/cancers16244213.

Evaluating nivolumab plus gemcitabine-cisplatin's cost-effectiveness for aUC in China.

Meng K, Xiang H, Wu M, Xie O, Li A, Tan C Front Pharmacol. 2024; 15:1382342.

PMID: 39564123 PMC: 11573544. DOI: 10.3389/fphar.2024.1382342.

Expression and clinicopathologic significance of HER2 and PD-L1 in high grade urothelial carcinoma of the urinary tract.

Li P, Ni P, Haines G, Si Q, Li X, Baskovich B Int J Clin Exp Pathol. 2024; 17(8):236-244.

PMID: 39262437 PMC: 11384330. DOI: 10.62347/AAPB6946.

Eligibility Criteria for Different Platinum-Based Chemotherapy Regimens in Metastatic Urothelial Carcinoma.

Azam F, Alharbi H, Alshangiti A, Zar Gul A, Bukhari N, Ouda M Cureus. 2024; 16(8):e66520.

PMID: 39246966 PMC: 11380918. DOI: 10.7759/cureus.66520.

References

Swartz M, Porter M, Lin D, Weiss N . Incidence of primary urethral carcinoma in the United States. Urology. 2006; 68(6):1164-8. DOI: 10.1016/j.urology.2006.08.1057. View

Gakis G, Witjes J, Comperat E, Cowan N, De Santis M, Lebret T . EAU guidelines on primary urethral carcinoma. Eur Urol. 2013; 64(5):823-30. DOI: 10.1016/j.eururo.2013.03.044. View

Latchamsetty K, Porter C . Treatment of upper tract urothelial carcinoma: a review of surgical and adjuvant therapy. Rev Urol. 2006; 8(2):61-70. PMC: 1578534. View

Lughezzani G, Burger M, Margulis V, Matin S, Novara G, Roupret M . Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012; 62(1):100-14. DOI: 10.1016/j.eururo.2012.02.030. View

Cassell A, Yunusa B, Jalloh M, Mbodji M, Diallo A, Ndoye M . Non-Muscle Invasive Bladder Cancer: A Review of the Current Trend in Africa. World J Oncol. 2019; 10(3):123-131. PMC: 6615913. DOI: 10.14740/wjon1210. View

Flaig T, Spiess P, Agarwal N, Bangs R, Boorjian S, Buyyounouski M . Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020; 18(3):329-354. DOI: 10.6004/jnccn.2020.0011. View

Cassell A, Yunusa B, Manobah B, Wambo D . Management guidelines of penile cancer- a contemporary review of sub-Saharan Africa. Infect Agent Cancer. 2020; 15:26. PMC: 7195778. DOI: 10.1186/s13027-020-00293-9. View

Klufio G . A review of genitourinary cancers at the Korle-Bu teaching hospital Accra, Ghana. West Afr J Med. 2004; 23(2):131-4. DOI: 10.4314/wajm.v23i2.28104. View

Gakis G, Morgan T, Efstathiou J, Keegan K, Mischinger J, Todenhoefer T . Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol. 2015; 34(1):97-103. PMC: 10176500. DOI: 10.1007/s00345-015-1583-7. View

10.

Cassell A, Jalloh M, Ndoye M, Yunusa B, Mbodji M, Diallo A . Review of Testicular Tumor: Diagnostic Approach and Management Outcome in Africa. Res Rep Urol. 2020; 12:35-42. PMC: 7035899. DOI: 10.2147/RRU.S242398. View

11.

Rabbani F . Prognostic factors in male urethral cancer. Cancer. 2013; 117(11):2426-34. DOI: 10.1002/cncr.25787. View

12.

Leow J, Chong K, Chang S, Bellmunt J . Upper tract urothelial carcinoma: a different disease entity in terms of management. ESMO Open. 2017; 1(6):e000126. PMC: 5419214. DOI: 10.1136/esmoopen-2016-000126. View

13.

Botteman M, Pashos C, Redaelli A, Laskin B, Hauser R . The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2004; 21(18):1315-30. DOI: 10.1007/BF03262330. View

14.

Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat E . EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. 2016; 71(3):447-461. DOI: 10.1016/j.eururo.2016.05.041. View

15.

Janisch F, Abufaraj M, Fajkovic H, Kimura S, Iwata T, Nyirady P . Current Disease Management of Primary Urethral Carcinoma. Eur Urol Focus. 2019; 5(5):722-734. DOI: 10.1016/j.euf.2019.07.001. View

16.

Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J . Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int. 2009; 104(10):1436-40. DOI: 10.1111/j.1464-410X.2009.08838.x. View

17.

Campi R, Minervini A, Mari A, Hatzichristodoulou G, Sessa F, Lapini A . Anatomical templates of lymph node dissection for upper tract urothelial carcinoma: a systematic review of the literature. Expert Rev Anticancer Ther. 2017; 17(3):235-246. DOI: 10.1080/14737140.2017.1285232. View

18.

Gatta G, van der Zwan J, Casali P, Siesling S, Dei Tos A, Kunkler I . Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011; 47(17):2493-511. DOI: 10.1016/j.ejca.2011.08.008. View

19.

Aleksic I, Rais-Bahrami S, Daugherty M, Agarwal P, Vourganti S, Bratslavsky G . Primary urethral carcinoma: A Surveillance, Epidemiology, and End Results data analysis identifying predictors of cancer-specific survival. Urol Ann. 2018; 10(2):170-174. PMC: 5907326. DOI: 10.4103/UA.UA_136_17. View

20.

Cassell A, Jalloh M, Yunusa B, Ndoye M, Mbodji M, Diallo A . Management of Renal Cell Carcinoma-Current Practice in Sub-Saharan Africa. J Kidney Cancer VHL. 2019; 6(2):1-9. PMC: 6898899. DOI: 10.15586/jkcvhl.2019.122. View